Angiotensin II inhibition reduces stress sensitivity of hypothalamo-pituitary-adrenal axis in spontaneously hypertensive rats

Endocrinology

Volumn 147, Issue 7, 2006, Pages 3539-3546

  Raasch, Walter ^a   Wittmershaus, Christian ^a   Dendorfer, Andreas ^a   Voges, Inga ^a   Pahlke, Friedrich ^a   Dodt, Christoph ^a   Dominiak, Peter ^a   Jöhren, Olaf ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN 1B RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; CANDESARTAN HEXETIL; CORTICOTROPIN; DIPEPTIDYL CARBOXYPEPTIDASE; HYDROCORTISONE; MESSENGER RNA; MIBEFRADIL; PROOPIOMELANOCORTIN; RAMIPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DOWN REGULATION; ENZYME INHIBITION; GENE EXPRESSION; HYDROCORTISONE BLOOD LEVEL; HYPERTENSION; HYPOPHYSIS; HYPOPHYSIS ADRENAL SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPONTANEOUSLY HYPERTENSIVE RAT; STATISTICAL SIGNIFICANCE; STRESS;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BLOOD PRESSURE; CORTICOSTERONE; GENE EXPRESSION REGULATION; HYPOTHALAMUS; MALE; MIBEFRADIL; PITUITARY-ADRENAL SYSTEM; RAMIPRIL; RATS; RATS, INBRED SHR; TETRAZOLES;

EID: 33745136818     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-0198     Document Type: Article

References (53)

1. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T 2000 International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52:415-472
2. Inagami T, Guo DF, Kitami Y 1994 Molecular biology of angiotensin II receptors: an overview. J Hypertens Suppl 12:S83-S94
3. Burson JM, Aguilera G, Gross KW, Sigmund CD 1994 Differential expression of angiotensin receptor 1A and 1B in mouse. Am J Physiol 267:E260-E267
4. Llorens-Cortes C, Greenberg B, Huang H, Corvol P 1994 Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis. Hypertension 24:538-548
5. Gasc JM, Shanmugam S, Sibony M, Corvol P 1994 Tissue-specific expression of type 1 angiotensin II receptor subtypes. An in situ hybridization study. Hypertension 24:531-537
6. Johren O, Inagami T, Saavedra JM 1995 AT1A, AT1B, and AT2 angiotensin II receptor subtype gene expression in rat brain. Neuroreport 6:2549-2552
7. Johren O, Saavedra JM 1996 Expression of AT1A and AT1B angiotensin II receptor messenger RNA in forebrain of 2-wk-old rats. Am J Physiol 271:E104-E112
8. Aguilera G, Kiss A, Luo X 1995 Increased expression of type 1 angiotensin II receptors in the hypothalamic paraventricular nucleus following stress and glucocorticoid administration. J Neuroendocrinol 7:775-783
9. Castren E, Saavedra JM 1988 Repeated stress increases the density of angiotensin II binding sites in rat paraventricular nucleus and subfornical organ. Endocrinology 122:370-372
10. 1 receptor antagonist decreases the hypothalamic-pituitary-adrenal response to isolation stress. Endocrinology 142:3880-3889
11. 2 receptors. Neuroendocrinology 75:227-240
12. Rivier C, Vale W 1983 Effect of angiotensin II on ACTH release in vivo: role of corticotropin-releasing factor. Regul Pept 7:253-258
13. Jezova D, Ochedalski T, Kiss A, Aguilera G 1998 Brain angiotensin II modulates sympathoadrenal and hypothalamic pituitary adrenocortical activation during stress. J Neuroendocrinol 10:67-72
14. Sumitomo T, Suda T, Nakano Y, Tozawa F, Yamada M, Demura H 1991 Angiotensin II increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus. Endocrinology 128:2248-2252
15. Abou-Samra AB, Catt KJ, Aguilera G 1986 Involvement of protein kinase C in the regulation of adrenocorticotropin release from rat anterior pituitary cells. Endocrinology 118:212-217
16. Schoenenberg P, Kehrer P, Muller AF, Gaillard RC 1987 Angiotensin II potentiates corticotropin-releasing activity of CRF41 in rat anterior pituitary cells: mechanism of action. Neuroendocrinology 45:86-90
17. Seltzer A, Bregonzio C, Armando I, Baiardi G, Saavedra JM 2004 Oral administration of an AT1 receptor antagonist prevents the central effects of angiotensin II in spontaneously hypertensive rats. Brain Res 1028:9-18
18. Johren O, Golsch C, Dendorfer A, Qadri F, Hauser W, Dominiak P 2003 Differential expression of AT1 receptors in the pituitary and adrenal gland of SHR and WKY. Hypertension 41:984-990
19. Nyklicek I, Bosch JA, Amerongen AV 2005 A generalized physiological hyperreactivity to acute stressors in hypertensives. Biol Psychol 70:44-51
20. Raasch W, Bartels T, Gieselberg A, Dendorfer A, Dominiak P 2002 Angiotensin I-converting enzyme inhibition increases cardiac catecholamine content and reduces monoamine oxidase activity via an angiotensin type 1 receptor-mediated mechanism. J Pharmacol Exp Ther 300:428-434
21. Raasch W, Johren O, Schwartz S, Gieselberg A, Dominiak P 2004 Combined blockade of AT1-receptors and ACE synergistically potentiates antihypertensive effects in SHR. J Hypertens 22:611-618
22. Johren O, Neidert SJ, Kummer M, Dendorfer A, Dominiak P 2001 Preproorexin and orexin receptor mRNAs are differentially expressed in peripheral tissues of male and female rats. Endocrinology 142:3324-3331
23. Madle A, Linhartova K, Koza J 2001 Effects of the T-type calcium channel blockade with oral mibefradil on the electrophysiologic properties of the human heart. Med Sci Monit 7:74-77
24. Robertson JI, Tillman DM 1987 Converting enzyme inhibitors in the treatment of hypertension. J Cardiovasc Pharmacol 10(Suppl 7):S43-S48
25. Aihara H, Ogawa H, Kasuya A, Yoshida M, Suzuki-Kusaba M, Hisa H, Satoh S 1999 Intrarenal angiotensin converting enzyme inhibition in spontaneously hypertensive rats. Eur J Pharmacol 373:35-40
26. Azizi M, Chatellier G, Guyene TT, Murieta-Geoffroy D, Menard J 1995 Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives. Circulation 92:825-834
27. Juillerat L, Nussberger J, Menard J, Mooser V, Christen Y, Waeber B, Graf P, Brunner HR 1990 Determinants of angiotensin II generation during converting enzyme inhibition. Hypertension 16:564-572
28. Karlberg BE, Rosenqvist U 1986 Antihypertensive and hormonal effects of lisinopril, a new angiotensin converting enzyme (ACE) inhibitor in patients with renovascular hypertension. Acta Med Scand Suppl 714:33-42
29. Schunkert H, Ingelfinger JR, Hirsch AT, Pinto Y, Remme WJ, Jacob H, Dzau VJ 1993 Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II. Circ Res 72:312-318
30. Filipovsky J, Ducimetiere P, Eschwege E, Richard JL, Rosselin G, Claude JR 1996 The relationship of blood pressure with glucose, insulin, heart rate, free fatty acids and plasma cortisol levels according to degree of obesity in middle-aged men. J Hypertens 14:229-235
31. Heaney AP, Ferguson T, Sheridan B, Atkinson AB 1995 Cortisol excretion in essential hypertension. J Hum Hypertens 9:947-951
32. Kornel L, Miyabo S, Saito Z, Cha RW, Wu FT 1975 Corticosteroids in human blood. VIII. Cortisol metabolites in plasma of normotensive subjects and patients with essential hypertension. J Clin Endocrinol Metab 40:949-958
33. Gold SM, Dziobek I, Rogers K, Bayoumy A, McHugh PF, Convit A 2005 Hypertension and hypothalamo-pituitary-adrenal axis hyperactivity affect frontal lobe integrity. J Clin Endocrinol Metab 90:3262-3267
34. al'Absi M, Lovallo WR, McKey BS, Pincomb GA 1994 Borderline hypertensives produce exaggerated adrenocortical responses to mental stress. Psychosom Med 56:245-250
35. Gaillard RC, Grossman A, Gillies G, Rees LH, Besser GM 1981 Angiotensin II stimulates the release of ACTH from dispersed rat anterior pituitary cells. Clin Endocrinol (Oxf) 15:573-578
36. Aguilera G, Harwood JP, Wilson JX, Morell J, Brown JH, Catt KJ 1983 Mechanisms of action of corticotropin-releasing factor and other regulators of corticotropin release in rat pituitary cells. J Biol Chem 258:8039-8045
37. Spinedi E, Negro-Vilar A 1983 Angiotensin II and ACTH release: site of action and potency relative to corticotropin releasing factor and vasopressin. Neuroendocrinology 37:446-453
38. Cameron VA, Espiner EA, Nicholls MG, MacFarlane MR, Sadler WA 1986 Intra-cerebroventricular captopril reduces plasma ACTH and vasopressin responses to hemorrhagic stress. Life Sci 38:553-559
39. Deininger E, Oltmanns KM, Wellhoener P, Fruehwald-Schultes B, Kern W, Heuer B, Dominiak P, Born J, Fehm HL, Peters A 2001 Losartan attenuates symptomatic and hormonal responses to hypoglycemia in humans. Clin Pharmacol Ther 70:362-369
40. Buckner FS, Chen FN, Wade CE, Ganong WF 1986 Centrally administered inhibitors of the generation and action of angiotensin II do not attenuate the increase in ACTH secretion produced by ether stress in rats. Neuroendocrinology 42:97-101
41. Hirasawa R, Hashimoto K, Ota Z 1990 Role of central angiotensinergic mechanism in shaking stress-induced ACTH and catecholamine secretion. Brain Res 533:1-5
42. Hollenberg NK, Williams GH, Adams DF 1981 Essential hypertension: abnormal renal vascular and endocrine responses to a mild psychological stimulus. Hypertension 3:11-17
43. Hubner N, Kreutz R, Takahashi S, Ganten D, Lindpaintner K 1995 Altered angiotensinogen amino acid sequence and plasma angiotensin II levels in genetically hypertensive rats. A study on cause and effect. Hypertension 26:279-284
44. Gaillard RC, Riondel AM, Ling N, Muller AF 1988 Corticotropin releasing factor activity of CRF 41 in normal man is potentiated by angiotensin II and vasopressin but not by desmopressin. Life Sci 43:1935-1944
45. Keller-Wood M, Kimura B, Shinsako J, Phillips MI 1986 Interaction between CRF and angiotensin II in control of ACTH and adrenal steroids. Am J Physiol 250:R396-R402
46. Spinedi E, Rodriguez G 1986 Angiotensin II and adrenocorticotropin release: mediation by endogenous corticotropin-releasing factor. Endocrinology 119:1397-1402
47. Saavedra JM 1992 Brain and pituitary angiotensin. Endocr Rev 13:329-380
48. Owens MJ, Nemeroff CB 1991 Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 43:425-473
49. Spinedi E, Aguado L, Basilotta G, Carrizo D 1989 Angiotensin II and glucocorticoid release: direct effect at the adrenal level and modulation of the adrenocorticotropin-induced glucocorticoid release. J Endocrinol Invest 12:321-327
50. Negro-Vilar A, Johnston C, Spinedi E, Valenca M, Lopez F 1987 Physiological role of peptides and amines on the regulation of ACTH secretion. Ann NY Acad Sci 512:218-236
51. Rozanski A, Blumenthal JA, Kaplan J 1999 Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 99:2192-2217
52. Surwit RS, Schneider MS, Feinglos MN 1992 Stress and diabetes mellitus. Diabetes Care 15:1413-1422
53. Chan O, Inouye K, Vranic M, Matthews SG 2002 Hyperactivation of the hypothalamo-pituitary-adrenocortical axis in streptozotocin-diabetes is associated with reduced stress responsiveness and decreased pituitary and adrenal sensitivity. Endocrinology 143:1761-1768